If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksImperial Innovations Group Regulatory News (IVO)

  • There is currently no data for IVO

Proof of Concept Programme

11 Dec 2007 11:18

Imperial Innovations Group plc11 December 2007 Imperial Innovations Group plc ("Imperial Innovations") Proof of Concept programme Imperial Innovations Group plc (AIM: IVO) today announces the creation of a newUS$1 million Proof of Concept ("PoC") programme which has been funded byShapoorji Pallonji & Company Limited ("SPCL") a diversified conglomerateincluding the oldest construction company based in India. The objective of the PoC programme is to validate and accelerate the developmentof emerging technologies at Imperial College London for spin-out opportunities.Imperial Innovations will manage the programme including the recommendation,selection, and commercial assessment of the projects. The company isparticularly interested in developing technologies with SPCL which may lead tomarket applications and follow-on joint development opportunities in India. The PoC programme will fund three to five technologies of twelve to eighteenmonths' duration over the next two years and will give priority to applicationsin the built environment, whether renewable energy or energy-efficiencyinnovations. The creation of the PoC programme with SPCL builds on Imperial Innovations'ongoing activities in India which is regarded as one of the most importanttechnology markets for the future, including the recent formation of i2india,the technology commercialisation company based in India. Susan Searle, CEO of Imperial Innovations said: "The launch of the Shapoorji Proof of Concept programme will help us qualifyinventions in our intellectual property portfolio for more focused spin-outopportunities. Pre-commercial funding is very difficult to obtain forearly-stage technologies therefore we are extremely grateful for the fundingSPCL has provided. We are also encouraged that influential companies such asSPCL turn to us to access next generation technologies." Mr. Pallonji Mistry, Chairman of Shapoorji Pallonji & Co. Ltd., Mumbai said: "We look forward to a mutually rewarding and long term relationship withImperial Innovations through promoting development projects in selected areas." -Ends- For more information contact: Imperial InnovationsSusan Searle, Chief Executive Officer +44 (0)20 7594 6591Lucy Ahfong, Marketing Communications Executive +44 (0)20 7594 6644 M:CommunicationsPatrick d'Ancona / Eleanor Williamson +44 (0)20 7153 1539 JPMorgan Cazenove (NOMAD to Imperial Innovations)Steve Baldwin +44(0)20 7588 2828 Notes to Editors About Imperial Innovations Imperial Innovations is one of the UK's leading technology transfer andcommercialisation companies. The company was founded in 1986 and its ordinaryshares admitted to trading on the AIM Market of London Stock Exchange plc inJuly 2006, raising £25 million at an offer price of 365p and £1 million by meansof a public offer. In November 2007, the company raised a further £30 million bymeans of a placing of new ordinary shares with investors. The company's integrated approach encompasses the identification of ideas,protection of intellectual property, development and licensing of technology andformation, incubation and investment in technology businesses. A wide range oftechnologies are commercialised within the areas of healthcare, energy,environment and emerging technology trends. Based at Imperial College London, the company has established equity holdings in74 technology businesses and is managing 133 commercial agreements as of 31 July2007. Imperial Innovations also commercialises technologies originating fromoutside Imperial College through incubation contracts with the Carbon Trust andWRAP and has commercialisation contracts with a number of multinationalcorporations including BAE Systems. www.imperialinnovations.co.uk About Shapoorji Pallonji & Company Ltd Shapoorji Pallonji & Company Ltd is a diversified conglomerate with businessinterests in the construction, finance, biotechnology, and energy sectors. Thecompany started 140 years ago in Mumbai as a construction company. ShapoorjiPallonji has grown from its origins as India's oldest construction company andhas developed an international reputation in delivering complex projectsincluding factories, nuclear research establishments, nuclear waste handling,scientific and research establishments, stadia and auditoria, airports, hotels,hospitals, giant skyscrapers, housing complexes, townships, water treatmentplants, roads, expressways, power plants and biotech facilities. It is thelargest private shareholder (18.5%) of TATA SONS Ltd, the Holding Company of theTATA Group. The annual turnover of the TATA Group is over US$15 billion. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
24th Jan 20117:00 amRNSResult of equity raise
6th Jan 20111:11 pmRNSResult of General Meeting
9th Dec 201011:10 amRNSDirectors' Dealings
8th Dec 20104:55 pmRNSPublication of Prospectus
7th Dec 20107:09 amRNS£140m equity raising
12th Oct 20107:00 amRNSFinal Results
15th Sep 20104:17 pmRNSNotice of Results
2nd Sep 20109:00 amRNSPortfolio News
25th Aug 20109:00 amRNSPortfolio Company News
20th Aug 20109:00 amRNSFurther portfolio investments
22nd Jun 201010:37 amRNSDirectors' Dealings
1st Jun 20107:01 amRNSSale of portfolio company
27th Apr 20107:00 amRNSInterim Results
23rd Apr 20109:05 amRNSMIT praises Novacem technology
9th Apr 20107:00 amRNSNotice of Results
6th Apr 20108:00 amRNSInvestment in portfolio company
11th Mar 20108:00 amRNSFurther Investment in portfolio company
8th Mar 20104:19 pmRNSChange of Adviser
5th Mar 201011:05 amRNSTR1 - Notification of major interest in shares
3rd Mar 20108:30 amRNSMilestone for Nexeon
2nd Mar 20107:16 amRNSMembrane Extraction Technology sold
1st Mar 20107:00 amRNSInvestment in portfolio company
17th Feb 20107:00 amRNSFurther Investment In PolyTherics
8th Feb 201012:41 pmRNSDirector Dealing
5th Feb 20103:42 pmRNSNotification of Major Interest in Shares
27th Jan 20107:00 amRNSLicence Agreement
19th Jan 20105:58 pmRNSDirector Dealings
19th Jan 201011:47 amRNSAdditional Listing of Shares
21st Dec 200911:32 amRNSBoard Appointment
15th Dec 200912:04 pmRNSResult of AGM
11th Dec 20097:00 amRNSFurther investment in portfolio company
8th Dec 200910:14 amRNSDirector Dealing's
27th Nov 200910:31 amRNSHolding(s) in Company
11th Nov 200911:42 amRNSNotice of AGM
21st Oct 20093:20 pmRNSDirector Dealings
20th Oct 20097:00 amRNSFurther Investment In Portfolio Company
13th Oct 20094:17 pmRNSDirector Dealing
12th Oct 20093:09 pmRNSDirectors' Dealings
8th Oct 20097:00 amRNSFurther Investment in Plaxica
7th Oct 20097:00 amRNSFinal Results
21st Sep 20097:00 amRNSInvestment in Portfolio Company
1st Sep 20097:00 amRNSLeads ?2 funding round in Molecular Vision
25th Aug 20093:30 pmRNSNotice of Results
10th Aug 20097:00 amRNSInvestments in portfolio companies
3rd Jul 20097:00 amRNSInvestment in OSspray
26th Jun 20097:00 amRNSDisposal of investment in InforSense
2nd Jun 20094:30 pmPRNHolding(s) in Company
28th May 20098:05 amRNSPortfolio Company IP Trade Sale to Technip
20th May 20097:00 amRNSDirector/PDMR Shareholding
27th Apr 20097:00 amPRNHalf-yearly Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.